7 line items awarded for hydralazine tablets. Awarded for a base year of 4/8/2021 to 4/7/2022 plus 4 one-year option periods.
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79721D0004
- Awardee
-
Radha Pharmaceuticals Inc. UEI C1S5SQ88KY67
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Hydralazine Tablets (VA-20-00075696) Pre-Solicitation · 36E79720R0064 · Posted Aug 5, 2020
- 6505--Hydralazine Tablets (VA-20-00075696) Effective 4/8/2021 - 4/7/2022 Award Notice · Posted Oct 28, 2020
- 6505--Hydralazine Tablets (VA-20-00075696) Solicitation · Posted Aug 21, 2020
- Last date to order 100% complete
- IDV ceiling
- $11,999,990.25
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) held by Radha Pharmaceuticals Inc., a minority-owned and small disadvantaged business, to provide various strengths and bottle configurations of hydralazine tablets to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service.
The $11,999,990.25 IDC has a base year period of performance from April 8, 2021 to April 7, 2022, with four one-year option periods, for a total potential period of performance through April 7, 2026. The contract utilizes firm-fixed pricing and aims to leverage the VA and DoD Pharmaceutical Prime Vendor programs to efficiently distribute these high-volume pharmaceutical products to government medical facilities. No set-asides were applied, and the contract was awarded under full and open competition following a pre-solicitation notice and subsequent Request for Proposal.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Exercise an Option | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79721D0004?
36E79721D0004 was awarded to Radha Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on April 8, 2021.
How much is contract 36E79721D0004 worth?
36E79721D0004's own ceiling is $11,999,990.
Who can order from contract 36E79721D0004?
36E79721D0004 is a single award indefinite delivery contract.
Was contract 36E79721D0004 competed?
The extent of competition for 36E79721D0004 was full and open competition. The government received 4 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV